AU2-94 demonstrated additive or synergistic effects when combined with enzalutamide. »
06/17/26

Highlighting unmet needs for integrating precision oncology into clinical practice. »
06/18/26

Sensitivity of breast cancer cells with 17q23 amplification to PLK4 inhibitor limited by activity of protein phosphatase. »
06/18/26

HRM analysis demonstrated shift in melting temperature consistent with altered nucleotide composition. »
06/18/26

Early infusion associated with significantly higher DCR. »
06/19/26

Exposure to JAG1 disrupted lymphatic endothelial barrier integrity. »
06/19/26

Displacement of CT1 significantly larger than that of CT2–4 in all directions. »
06/19/26

Tumors located at ureteral orifice associated with increased recurrence risk. »
06/20/26

PIK3CAm not found to be associated with worse OS. »
06/20/26

RF3 and RF7 significantly negatively correlated with key IDH mutation genes. »
06/21/26